These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 33338321)
21. Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies. Dong ZY; Zhang C; Li YF; Su J; Xie Z; Liu SY; Yan LX; Chen ZH; Yang XN; Lin JT; Tu HY; Yang JJ; Zhou Q; Sun YL; Zhong WZ; Wu YL J Thorac Oncol; 2018 Jan; 13(1):85-96. PubMed ID: 29127022 [TBL] [Abstract][Full Text] [Related]
22. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer. Luo C; Chen J; Chen L Int Immunopharmacol; 2020 Sep; 86():106709. PubMed ID: 32593155 [TBL] [Abstract][Full Text] [Related]
23. T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer. Obradovic AZ; Dallos MC; Zahurak ML; Partin AW; Schaeffer EM; Ross AE; Allaf ME; Nirschl TR; Liu D; Chapman CG; O'Neal T; Cao H; Durham JN; Guner G; Baena-Del Valle JA; Ertunc O; De Marzo AM; Antonarakis ES; Drake CG Clin Cancer Res; 2020 Jul; 26(13):3182-3192. PubMed ID: 32173650 [TBL] [Abstract][Full Text] [Related]
24. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures. Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127 [TBL] [Abstract][Full Text] [Related]
25. Advances in and prospects of immunotherapy for prostate cancer. Liu D; Wang L; Guo Y Cancer Lett; 2024 Oct; 601():217155. PubMed ID: 39127338 [TBL] [Abstract][Full Text] [Related]
26. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer. Zeng H; Huang Y; Chen L; Li H; Ma X Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354 [TBL] [Abstract][Full Text] [Related]
27. Genomic stratification based on microenvironment immune types and PD-L1 for tailoring therapeutic strategies in bladder cancer. Lyu X; Wang P; Qiao Q; Jiang Y BMC Cancer; 2021 May; 21(1):646. PubMed ID: 34059019 [TBL] [Abstract][Full Text] [Related]
28. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
29. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Liu D; Yang X; Wu X Front Immunol; 2021; 12():663495. PubMed ID: 34025664 [TBL] [Abstract][Full Text] [Related]
30. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy. Peng S; Hu P; Xiao YT; Lu W; Guo D; Hu S; Xie J; Wang M; Yu W; Yang J; Chen H; Zhang X; Zhu Y; Wang Y; Yang Y; Zhu G; Chen S; Wang J; Zhang B; Chen W; Wu H; Sun Z; Ding T; Zhang H; Yi Z; Liu M; Ren S Clin Cancer Res; 2022 Feb; 28(3):552-567. PubMed ID: 34740924 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H Front Immunol; 2021; 12():769425. PubMed ID: 34804059 [TBL] [Abstract][Full Text] [Related]
32. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899 [TBL] [Abstract][Full Text] [Related]
33. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature. Zhang S; Lv M; Cheng Y; Wang S; Li C; Qu X BMC Cancer; 2021 Dec; 21(1):1324. PubMed ID: 34893046 [TBL] [Abstract][Full Text] [Related]
35. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D Front Immunol; 2023; 14():1181370. PubMed ID: 37600770 [TBL] [Abstract][Full Text] [Related]
36. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival. Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E Front Immunol; 2021; 12():778329. PubMed ID: 34975867 [TBL] [Abstract][Full Text] [Related]
37. Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation. von Hardenberg J; Hartmann S; Nitschke K; Worst TS; Ting S; Reis H; Nuhn P; Weis CA; Erben P Clin Genitourin Cancer; 2019 Apr; 17(2):145-153.e5. PubMed ID: 30709785 [TBL] [Abstract][Full Text] [Related]
38. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer. Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405 [No Abstract] [Full Text] [Related]
39. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer. Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067 [TBL] [Abstract][Full Text] [Related]
40. High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot. Keam SP; Halse H; Nguyen T; Wang M; Van Kooten Losio N; Mitchell C; Caramia F; Byrne DJ; Haupt S; Ryland G; Darcy PK; Sandhu S; Blombery P; Haupt Y; Williams SG; Neeson PJ J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]